ESPR vs CDMO

Comparison between Esperion Therapeutics Inc (ESPR, Company) and Avid Bioservices Inc (CDMO, Company).

5-Year PerformanceCDMO has outperformed ESPR, delivering a return of +13.9% compared to -29.6%

ESPR vs CDMO - Performance Comparison

Log

Key Characteristics

Financial metrics and valuation ratios

Metric	ESPR(COMPANY)	CDMO(COMPANY)
Market Cap	$799M	$797M
Max Drawdown	99.37%	86.42%
Sharpe Ratio	1.41	1.31
5Y Beta	1.29	N/A
Industry	Drug Manufacturers - Specialty & Generic	N/A
P/E Ratio	-6.03	-5.20
Forward P/E	4.64	N/A
PEG Ratio	-0.75	N/A
5Y EPS CAGR	-31.57%	N/A
Debt to Equity	0.00%	358.17%
Free Cash Flow Yield	-2.30%	-1.21%
P/S Ratio	1.96	5.30
P/B Ratio	98.42	17.79

Market Cap

Winner

ESPR

$799M

CDMO

$797M

Max Drawdown

ESPR

99.37%

Winner

CDMO

86.42%

Sharpe Ratio

Winner

ESPR

1.41

CDMO

1.31

5Y Beta

ESPR

1.29

CDMO

N/A

Industry

ESPR

Drug Manufacturers - Specialty & Generic

CDMO

N/A

P/E Ratio

Winner

ESPR

-6.03

CDMO

-5.20

Forward P/E

ESPR

4.64

CDMO

N/A

PEG Ratio

ESPR

-0.75

CDMO

N/A

5Y EPS CAGR

ESPR

-31.57%

CDMO

N/A

Debt to Equity

Winner

ESPR

0.00%

CDMO

358.17%

Free Cash Flow Yield

ESPR

-2.30%

Winner

CDMO

-1.21%

P/S Ratio

Winner

ESPR

1.96

CDMO

5.30

P/B Ratio

ESPR

98.42

Winner

CDMO

17.79

ESPR vs CDMO - Historical Returns

Returns include dividend reinvestment.

Period	ESPR	CDMO
1 month	+0.95%	+1.05%
3 months	+43.24%	+18.50%
6 months	-3.64%	+18.84%
1 year	+169.49%	+99.20%
5 years(CAGR)	-29.55%	+13.88%
10 years(CAGR)	-11.39%	N/A
Max(CAGR)	-10.98%	+20.82%

ESPR

+0.95%

Winner

CDMO

+1.05%

Winner

ESPR

+43.24%

CDMO

+18.50%

ESPR

-3.64%

Winner

CDMO

+18.84%

Winner

ESPR

+169.49%

CDMO

+99.20%

5Y(CAGR)

ESPR

-29.55%

Winner

CDMO

+13.88%

10Y(CAGR)

ESPR

-11.39%

CDMO

N/A

Max(CAGR)

ESPR

-10.98%

Winner

CDMO

+20.82%

ESPR vs CDMO - Annual Returns (2013 - 2026)

Returns include dividend reinvestment.

Year	ESPR	CDMO
2026	-14.29%	N/A
2025	+68.18%	+1.38%
2024	-24.66%	+94.18%
2023	-48.80%	-51.78%
2022	+20.04%	-50.34%
2021	-81.96%	+146.04%
2020	-57.61%	+56.16%
2019	+30.45%	+79.63%
2018	-30.83%	+25.18%
2017	+411.18%	N/A
2016	-42.17%	N/A
2015	-46.01%	N/A
2014	+191.35%	N/A
2013	-5.24%	N/A

ESPR vs CDMO Drawdown Comparison

The maximum drawdown for ESPR was -99.37%, occurring on May 14, 2025. This drawdown has not yet recovered.

The maximum drawdown for CDMO was -86.42%, occurring on Dec 8, 2023. This drawdown has not yet recovered.

The current ESPR drawdown is -97.24%. The current CDMO drawdown is -63.46%.

Rank	ESPR	CDMO
#1	-99.37% May 19, 2015 - May 14, 2025	-86.42% Nov 5, 2021 - Dec 8, 2023
#2	-41.24% Oct 2, 2013 - Sep 26, 2014	-61.40% Dec 26, 2019 - Aug 13, 2020
#3	-28.66% Oct 8, 2014 - Oct 31, 2014	-53.14% Aug 31, 2018 - Dec 12, 2019
#4	-22.60% Mar 23, 2015 - May 19, 2015	-44.83% Jan 9, 2018 - Apr 4, 2018
#5	-18.82% Aug 5, 2013 - Sep 26, 2013	-32.73% Aug 10, 2021 - Oct 26, 2021
#6	-13.95% Oct 31, 2014 - Nov 12, 2014	-26.46% Mar 1, 2021 - Apr 28, 2021
#7	-12.84% Jan 14, 2015 - Feb 3, 2015	-21.10% Aug 19, 2020 - Nov 12, 2020
#8	-12.54% Dec 9, 2014 - Dec 31, 2014	-20.51% Apr 26, 2018 - Jun 27, 2018
#9	-12.35% Feb 18, 2015 - Mar 12, 2015	-12.36% Jul 20, 2018 - Aug 24, 2018
#10	-10.06% Nov 18, 2014 - Dec 4, 2014	-11.68% Apr 28, 2021 - Jun 3, 2021
#11	-6.74% Jan 12, 2015 - Jan 14, 2015	-7.94% Apr 4, 2018 - Apr 24, 2018
#12	-6.30% Jan 8, 2015 - Jan 12, 2015	-6.84% Dec 4, 2020 - Dec 18, 2020
#13	-3.45% Jun 26, 2013 - Jul 2, 2013	-6.70% Feb 8, 2021 - Feb 24, 2021
#14	-3.06% Jul 16, 2013 - Jul 29, 2013	-6.29% Jul 10, 2018 - Jul 17, 2018
#15	-2.87% Sep 26, 2014 - Sep 30, 2014	-6.27% Jul 8, 2021 - Aug 9, 2021

Correlation

Correlation between ESPR and CDMO is -0.56 which considered as a moderate negative correlation - the stocks show some tendency to move in opposite directions.

-0.56

-101